Pentoxifylline and cyclosporine in the treatment of febrile ulceronecrotic Mucha-Habermann disease

Miranda A. Uzoma, Michael Wilkerson, Vicki L. Carr, Gail S. Westhoven, Sharon Raimer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We describe two pediatric cases of febrile ulceronecrotic Mucha-Habermann disease (FUMHD) with response to pentoxifylline and cyclosporine therapies. Based on our review of the literature, we are presenting the first case of FUMHD treated with pentoxifylline and the third case of FUMHD successfully treated with cyclosporine. These agents may be of therapeutic benefit in the treatment of FUMHD, in part by suppressing tumor necrosis factor-alpha, which we believe may mediate the disease process.

Original languageEnglish (US)
Pages (from-to)525-527
Number of pages3
JournalPediatric Dermatology
Volume31
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Pentoxifylline
Cyclosporine
Tumor Necrosis Factor-alpha
Pediatrics
Febrile Ulceronecrotic Mucha-Habermann disease
Therapeutics

ASJC Scopus subject areas

  • Dermatology
  • Pediatrics, Perinatology, and Child Health

Cite this

Pentoxifylline and cyclosporine in the treatment of febrile ulceronecrotic Mucha-Habermann disease. / Uzoma, Miranda A.; Wilkerson, Michael; Carr, Vicki L.; Westhoven, Gail S.; Raimer, Sharon.

In: Pediatric Dermatology, Vol. 31, No. 4, 2014, p. 525-527.

Research output: Contribution to journalArticle

Uzoma, Miranda A. ; Wilkerson, Michael ; Carr, Vicki L. ; Westhoven, Gail S. ; Raimer, Sharon. / Pentoxifylline and cyclosporine in the treatment of febrile ulceronecrotic Mucha-Habermann disease. In: Pediatric Dermatology. 2014 ; Vol. 31, No. 4. pp. 525-527.
@article{6347e3664d294cb19b23dd30fd40cb55,
title = "Pentoxifylline and cyclosporine in the treatment of febrile ulceronecrotic Mucha-Habermann disease",
abstract = "We describe two pediatric cases of febrile ulceronecrotic Mucha-Habermann disease (FUMHD) with response to pentoxifylline and cyclosporine therapies. Based on our review of the literature, we are presenting the first case of FUMHD treated with pentoxifylline and the third case of FUMHD successfully treated with cyclosporine. These agents may be of therapeutic benefit in the treatment of FUMHD, in part by suppressing tumor necrosis factor-alpha, which we believe may mediate the disease process.",
author = "Uzoma, {Miranda A.} and Michael Wilkerson and Carr, {Vicki L.} and Westhoven, {Gail S.} and Sharon Raimer",
year = "2014",
doi = "10.1111/j.1525-1470.2012.01862.x",
language = "English (US)",
volume = "31",
pages = "525--527",
journal = "Pediatric Dermatology",
issn = "0736-8046",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Pentoxifylline and cyclosporine in the treatment of febrile ulceronecrotic Mucha-Habermann disease

AU - Uzoma, Miranda A.

AU - Wilkerson, Michael

AU - Carr, Vicki L.

AU - Westhoven, Gail S.

AU - Raimer, Sharon

PY - 2014

Y1 - 2014

N2 - We describe two pediatric cases of febrile ulceronecrotic Mucha-Habermann disease (FUMHD) with response to pentoxifylline and cyclosporine therapies. Based on our review of the literature, we are presenting the first case of FUMHD treated with pentoxifylline and the third case of FUMHD successfully treated with cyclosporine. These agents may be of therapeutic benefit in the treatment of FUMHD, in part by suppressing tumor necrosis factor-alpha, which we believe may mediate the disease process.

AB - We describe two pediatric cases of febrile ulceronecrotic Mucha-Habermann disease (FUMHD) with response to pentoxifylline and cyclosporine therapies. Based on our review of the literature, we are presenting the first case of FUMHD treated with pentoxifylline and the third case of FUMHD successfully treated with cyclosporine. These agents may be of therapeutic benefit in the treatment of FUMHD, in part by suppressing tumor necrosis factor-alpha, which we believe may mediate the disease process.

UR - http://www.scopus.com/inward/record.url?scp=84904572029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904572029&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1470.2012.01862.x

DO - 10.1111/j.1525-1470.2012.01862.x

M3 - Article

C2 - 23005254

AN - SCOPUS:84904572029

VL - 31

SP - 525

EP - 527

JO - Pediatric Dermatology

JF - Pediatric Dermatology

SN - 0736-8046

IS - 4

ER -